Accreditation 2022

Intended Audience

This educational activity is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with GI cancers, community oncologists, physicians, physician assistants, physicians-in-training, oncology nurses, and pharmacists.

Learning Objectives

Upon successful completion of these educational activities, participants should be able to:

  1. Analyze the mechanism of action (MOA) and safety-efficacy profiles of currently approved and emerging oncological agents including immunotherapies and molecularly targeted agents for the management of GI malignancies
  2. Integrate clinical trial data and evidence-based therapies for improving clinical outcomes in patients with GI malignancies
  3. Evaluate the best practices and standards of care based on a multidisciplinary approach for the management of GI cancers
  4. Implement the rational use of immunotherapies in patients with GI malignancies on a case-by-case basis
  5. Define patient populations most suitable for enrolling in GI clinical trials for progressive advanced stage GI malignancies
  6. Implement optimal management strategies for both metastatic and non-metastatic GI malignancies based on personalized factors such as comorbidities, cost, disease stage, and prior therapeutic regimens
  7. Evaluate the role of blood-based molecular profiling approaches for early diagnosis of metastatic disease and treatment monitoring
  8. Explore the more clearly defined role of neoadjuvant and adjuvant strategies in GI malignancies
  9. Explore the emerging role of blood based molecular markers of minimal residual disease, dynamic evaluation of patients on therapy to identify emergence of therapy resistance, and how these biomarkers will define treatment of adjuvant therapy patients and advanced disease
  10. Define the expanding role of interventional radiology in therapeutics
  11. Define the emerging role of ablative radiotherapy strategies in GI malignancies

Accreditation Statement

Image removed.In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Imedex. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.

Please visit each page for specific credit hours designated per activity. 

PRIVACY POLICY

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act, and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609.371.1137.

GRIEVANCE POLICY

Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at sconforti@naccme.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. The Manager, Accreditation and Compliance will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Greaton Sellers, Accreditation and Compliance, can be requested for a second level of review. Mr. Sellers can be contacted via email at gsellers@naccme.com.

Marketing and Management Company

HMP-Logo-Tag-1_4C_0_0.png

HMP | Healthcare Made Practical

70 East Swedesford Road, Suite 100
Malvern, PA 19355
Toll-Free: 800.237.7285
Phone: 610.560.0500
Fax: 610.560.0502

hmpglobal.com

CME/CE Provider

NACCME-HMP-Logo-Tag_4C_0.png
North American Center for Continuing Medical Education, LLC
An HMP Company

104 Windsor Center Drive, Suite 200
East Windsor, NJ 08520
Phone: 609.371.1137
Fax: 609.371.2733
naccme.com